The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Dr Reddy's Laboratories Faces Rs 28.7 Lakh Penalty in Kazakhstan
Dr Reddy's Laboratories has been penalized Rs 28.7 lakh by the Kazakhstan revenue authority for disallowing certain expense claims for the calendar year 2021. The penalty, amounting to KZT 17,597,212, was imposed by the Department of State Revenue in Almaty. The company stated that this will not materially impact its financials or operations.
Dr Reddy's launches Toripalimab for nasopharyngeal carcinoma in India
Dr Reddy's Laboratories has launched Toripalimab, the first immunooncology drug approved for nasopharyngeal carcinoma, in India. This follows a licensing agreement with Shanghai Junshi Biosciences, granting exclusive rights to market the drug in 21 countries, including India. With this launch, India becomes the third country to access Toripalimab, marketed as Zytorvi, addressing a significant need for advanced NPC treatment.
Dr Reddy's launches Zytorvi for rare head and neck cancer treatment
India's medical technology industry aims for USD 20 billion in exports by 2030, seeking government support for growth. Aster DM Healthcare is merging with Blackstone's Care Hospitals, creating a major hospital chain, while mental health searches in India surged 41% in 2024, highlighting a growing focus on wellness.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.